|
"余明隆"的相關文件
顯示項目 6-15 / 304 (共31頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 高雄醫學大學 |
2014 |
Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice
|
林志文;Lo, S;彭道雄;吳秉家;Lee, PH;Chang, YF;郭柏麟;余明隆;袁行修;謝雅晶; Lin, CW;Lo, S;Perng, DS;Wu, DB;Lee, PH;Chang, YF;Kuo, PL;Yu, ML;Yuan, SS;Hsieh, YC. |
| 高雄醫學大學 |
2014 |
Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
|
葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu |
| 高雄醫學大學 |
2014 |
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
|
林昆德;李美月;馮久哲;Chen, Brian-Ken;余明隆;辛錫璋; Lin, KD;Lee, MY;Feng, CC;Chen, BK;Yu, ML;Shin, SJ |
| 高雄醫學大學 |
2013 |
Host factors determining the efficacy of hepatitis C treatment.
|
莊萬龍;余明隆 ; Chuang, WL;Yu, ML. |
| 高雄醫學大學 |
2013 |
非肝癌癌症C型肝炎患者接受長效型干擾素合併雷巴威靈治療之療效與安全性多中心研究
|
黃釧峰;黃志富;陳武政;葉明倫;黃駿逸;楊正福;莊萬龍;戴嘉言;謝明彥;林子堯;陳信成;余明隆; Huang, Chung-Feng;Huang, Jee-Fu;Chen, Wu-Cheng;Yeh, Ming-Lun;Huang, Ching-I;Yang, Jeng-Fu;Chuang, Wan-Long;Dai, Chia-Yen;Hsieh, Ming-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Yu, Ming-Lung |
| 高雄醫學大學 |
2013 |
亞洲慢性B型肝炎e抗原陽性病患接受干安能治療之鞏固療法:一多中心研究
|
戴嘉言;曾岱宗;Wong, Grace;黃志富;Wong, Vicent;劉俊人;余明隆;莊萬龍;高嘉宏;陳力元;陳定信 ; Dai, Chia-Yen;Tseng, Tai-Chung;Wong, Grace;Huang, Jee-Fu;Wong, Vicent;Liu, Chun-Jen;Yu, Ming-Lung;Chuang, Wan-Long;Kao, Jia-Horng;Chan, Henry;Chen , Ding-Sjinn |
| 高雄醫學大學 |
2013 |
Sustained hcv clearance and increased HBsAg seroclearance in patients with dual chronic hepatitis C and B during post-treatment follow-up.
|
余明隆;李詮謀;Chen, CL;莊萬龍;盧勝男;劉振樺;Wu, SS;廖麗瑛;郭行道;趙有誠;董水義;楊賢馨;高嘉宏;Su, WW;Lin, CL;Yang, HC;陳培哲;陳定信;劉俊人*;Taiwan Liver-Net, Consortium. ; Yu, ML;Lee, CM;Chen, CL;Chuang, WL;Lu, SN;Liu, CH;Wu, SS;Liao, LY;Kuo, HT;Chao, YC;Tung, SY;Yang, SS;Kao, JH;Su, WW;Lin, CL;Yang, HC;Chen, PJ;Chen, DS;Liu, CJ;Taiwan Liver-Net, Consortium. |
| 高雄醫學大學 |
2013 |
The Evolution of HCV treatment in Taiwan
|
黃釧峰;莊萬龍;余明隆; Huang, CF;Chaung, WL;Yu, ML |
顯示項目 6-15 / 304 (共31頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
